- Home
- BWEN vs ESLA Comparison
BWEN vs ESLA Comparison
Compare BWEN & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BWEN | ESLA |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 60.9M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | BWEN | ESLA |
|---|---|---|
| Price | $2.69 | $1.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $8.00 |
| AVG Volume (30 Days) | 125.9K | ★ 160.4K |
| Earning Date | 05-14-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 360.00 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $146,785,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.37 | N/A |
| P/E Ratio | $11.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.49 | $0.78 |
| 52 Week High | $4.15 | $3.15 |
Technical Indicators
Market Signals| Indicator | BWEN | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 61.47 | 56.20 |
| Support Level | $1.95 | $1.48 |
| Resistance Level | $2.78 | $2.07 |
| Average True Range (ATR) | 0.19 | 0.17 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 73.33 | 48.01 |
Price Performance
Historical ComparisonAbout BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.